Scribd
Upload
23 views10 pages

Krebs Biochem

Krebs Biochemicals & Industries Ltd has shown fluctuating sales and expenses from 2015 to 2024, with significant operating losses and negative net profits throughout the years. The company has not paid dividends and has a high level of borrowings compared to its equity. Recent quarterly reports indicate continued losses, with a net profit of -6.94 in March 2023 and an operating profit margin remaining negative.

Uploaded by

jyotiba1127
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
23 views10 pages

Krebs Biochem

Krebs Biochemicals & Industries Ltd has shown fluctuating sales and expenses from 2015 to 2024, with significant operating losses and negative net profits throughout the years. The company has not paid dividends and has a high level of borrowings compared to its equity. Recent quarterly reports indicate continued losses, with a net profit of -6.94 in March 2023 and an operating profit margin remaining negative.

Uploaded by

jyotiba1127
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
You are on page 1/ 10

KREBS BIOCHEMICALS & INDUSTRIES LTD SCREENER.

IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Trailing Best Case Worst Case
Sales - 1.14 3.23 33.78 47.76 33.41 53.70 59.70 52.13 50.42 49.19 49.37 49.22
Expenses 4.90 13.54 11.23 41.28 57.52 51.97 71.27 93.70 67.91 59.14 61.93 49.37 49.22
Operating Profit -4.90 -12.40 -8.00 -7.50 -9.76 -18.56 -17.57 -34.00 -15.78 -8.72 -12.74 - -
Other Income 2.96 1.31 -0.33 -1.01 0.44 0.37 0.62 1.16 0.62 0.45 0.58 - -
Depreciation 1.87 4.49 4.23 4.15 4.40 4.68 5.12 6.30 6.56 6.77 6.79 6.79 6.79
Interest 4.03 0.74 3.49 5.17 6.29 6.00 6.28 5.39 2.97 4.69 5.57 5.57 5.57
Profit before tax -7.84 -16.32 -16.05 -17.83 -20.01 -28.87 -28.35 -44.53 -24.69 -19.73 -24.52 -12.36 -12.36
Tax - - - - - - - - - - - 0% 0%
Net profit -7.84 -16.32 -16.05 -17.82 -20.01 -28.87 -28.36 -44.53 -24.69 -19.73 -24.52 -12.36 -12.36
EPS -6.82 -10.33 -9.67 -10.73 -12.05 -16.04 -14.47 -20.62 -11.43 -9.13 -11.37 -5.73 -5.73
Price to earning -12.58 -9.80 -8.98 -15.98 -9.49 -4.85 -5.94 -6.94 -4.94 -6.73 - - -
Price 85.78 101.26 86.79 171.56 114.45 77.75 85.95 143.05 56.50 61.45 66.37 - -

RATIOS:
Dividend Payout 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
OPM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST


Sales Growth 48.08% 1.09% -2.08% -2.44% -2.08% -2.44%
OPM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Price to Earning - - -
KREBS BIOCHEMICALS & INDUSTRIES LTD SCREENER.IN

Narration Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 Dec-24
Sales 20.94 9.09 11.46 10.58 14.89 12.98 11.97 12.89 12.86 11.47
Expenses 22.84 12.07 16.08 13.20 15.79 15.07 15.09 15.08 15.58 16.18
Operating Profit -1.90 -2.98 -4.62 -2.62 -0.90 -2.09 -3.12 -2.19 -2.72 -4.71
Other Income 0.27 0.02 0.19 0.04 0.17 0.03 0.21 0.03 0.09 0.25
Depreciation 1.69 1.69 1.48 1.65 1.71 1.73 1.67 1.69 1.71 1.72
Interest 0.74 0.90 1.03 1.10 1.13 1.19 1.27 1.32 1.42 1.56
Profit before tax -4.06 -5.55 -6.94 -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74
Tax - - - - - - - - - -
Net profit -4.06 -5.55 -6.94 -5.33 -3.57 -4.98 -5.85 -5.17 -5.76 -7.74

OPM -9% -33% -40% -25% -6% -16% -26% -17% -21% -41%
KREBS BIOCHEMICALS & INDUSTRIES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Equity Share Capital 9.51 13.06 13.74 13.74 16.63 18.00 19.62 21.56 21.56 21.56
Reserves 8.76 -0.05 -12.27 -31.52 -30.92 -43.00 -62.35 -96.65 -121.02 -140.78
Borrowings 60.91 30.57 47.55 56.21 53.38 66.22 111.14 143.10 183.37 193.68
Other Liabilities 29.26 72.84 73.06 87.44 103.27 92.58 90.81 121.79 91.07 103.72
Total 108.44 116.42 122.08 125.87 142.36 133.80 159.22 189.80 174.98 178.18

Net Block 58.44 93.10 102.17 100.77 101.27 105.29 117.93 138.71 147.31 149.96
Capital Work in Progress - 10.54 3.50 3.73 3.48 4.19 11.94 8.38 4.09 2.00
Investments - - - - - - - - - -
Other Assets 50.00 12.78 16.41 21.37 37.61 24.32 29.35 42.71 23.58 26.22
Total 108.44 116.42 122.08 125.87 142.36 133.80 159.22 189.80 174.98 178.18

Working Capital 20.74 -60.06 -56.65 -66.07 -65.66 -68.26 -61.46 -79.08 -67.49 -77.50
Debtors 0.37 0.03 1.59 0.32 2.91 0.20 0.30 0.88 0.53 1.90
Inventory 5.45 5.64 5.45 11.73 8.96 15.00 16.60 25.56 11.95 9.80

Debtor Days - 9.61 179.67 3.46 22.24 2.18 2.04 5.38 3.71 13.75
Inventory Turnover - 0.20 0.59 2.88 5.33 2.23 3.23 2.34 4.36 5.14

Return on Equity -43% -125% -1092%


Return on Capital Emp -25% -27% -29% -35% -57% -40% -57% -29% -19%
KREBS BIOCHEMICALS & INDUSTRIES LTD SCREENER.IN

Narration Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Cash from Operating Activity -45.26 -15.26 -11.20 -6.19 3.90 -35.50 -14.57 -17.22 -24.71 2.30
Cash from Investing Activity -2.92 -4.00 -4.70 -2.77 -4.32 -10.22 -22.55 -22.90 -12.65 -7.82
Cash from Financing Activity 54.13 13.22 15.75 9.26 17.32 28.58 37.66 39.51 37.34 5.56
Net Cash Flow 5.95 -6.04 -0.15 0.30 16.90 -17.14 0.54 -0.61 -0.01 0.05
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.


Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.


Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: [email protected]
s… do ANYTHING.
COMPANY NAME KREBS BIOCHEMICALS & INDUSTRIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 2.16
Face Value 10.00
Current Price 66.37
Market Capitalization 143.10

PROFIT & LOSS


Report Date Mar-15 Mar-16 Mar-17 Mar-18
Sales 1.14 3.23 33.78
Raw Material Cost 1.77 1.34 17.12
Change in Inventory 1.63 0.42 4.42
Power and Fuel 0.28 2.87 0.70 8.62
Other Mfr. Exp 0.67 1.71 1.22 4.79
Employee Cost 2.03 6.16 6.20 12.05
Selling and admin 0.75 2.64 1.95 2.87
Other Expenses 1.17 0.02 0.24 0.25
Other Income 2.96 1.31 -0.33 -1.01
Depreciation 1.87 4.49 4.23 4.15
Interest 4.03 0.74 3.49 5.17
Profit before tax -7.84 -16.32 -16.05 -17.83
Tax
Net profit -7.84 -16.32 -16.05 -17.82
Dividend Amount

Quarters
Report Date Sep-22 Dec-22 Mar-23 Jun-23
Sales 20.94 9.09 11.46 10.58
Expenses 22.84 12.07 16.08 13.20
Other Income 0.27 0.02 0.19 0.04
Depreciation 1.69 1.69 1.48 1.65
Interest 0.74 0.90 1.03 1.10
Profit before tax -4.06 -5.55 -6.94 -5.33
Tax
Net profit -4.06 -5.55 -6.94 -5.33
Operating Profit -1.90 -2.98 -4.62 -2.62

BALANCE SHEET
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 9.51 13.06 13.74 13.74
Reserves 8.76 -0.05 -12.27 -31.52
Borrowings 60.91 30.57 47.55 56.21
Other Liabilities 29.26 72.84 73.06 87.44
Total 108.44 116.42 122.08 125.87
Net Block 58.44 93.10 102.17 100.77
Capital Work in Progress 10.54 3.50 3.73
Investments
Other Assets 50.00 12.78 16.41 21.37
Total 108.44 116.42 122.08 125.87
Receivables 0.37 0.03 1.59 0.32
Inventory 5.45 5.64 5.45 11.73
Cash & Bank 6.31 0.27 0.12 0.42
No. of Equity Shares 9,514,000.00 13,064,300.00 13,744,300.00 13,744,000.00
New Bonus Shares
Face value 10.00 10.00 10.00 10.00

CASH FLOW:
Report Date Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity -45.26 -15.26 -11.20 -6.19
Cash from Investing Activity -2.92 -4.00 -4.70 -2.77
Cash from Financing Activity 54.13 13.22 15.75 9.26
Net Cash Flow 5.95 -6.04 -0.15 0.30

PRICE: 85.78 101.26 86.79 171.56

DERIVED:
Adjusted Equity Shares in Cr 1.15 1.58 1.66 1.66
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24


47.76 33.41 53.70 59.70 52.13 50.42
20.99 19.18 25.62 46.18 19.81 5.52
-2.11 3.32 -0.32 5.54 -5.87 -1.07
11.70 10.28 15.91 22.23 14.80 22.01
4.27 6.95 10.48 9.64 7.17 9.75
15.00 15.14 15.88 15.36 15.88 16.52
3.24 3.43 2.81 5.71 4.23 4.15
0.21 0.31 0.25 0.12 0.15 0.12
0.44 0.37 0.62 1.16 0.62 0.45
4.40 4.68 5.12 6.30 6.56 6.77
6.29 6.00 6.28 5.39 2.97 4.69
-20.01 -28.87 -28.35 -44.53 -24.69 -19.73

-20.01 -28.87 -28.36 -44.53 -24.69 -19.73

Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 Dec-24


14.89 12.98 11.97 12.89 12.86 11.47
15.79 15.07 15.09 15.08 15.58 16.18
0.17 0.03 0.21 0.03 0.09 0.25
1.71 1.73 1.67 1.69 1.71 1.72
1.13 1.19 1.27 1.32 1.42 1.56
-3.57 -4.98 -5.85 -5.17 -5.76 -7.74
-3.57 -4.98 -5.85 -5.17 -5.76 -7.74
-0.90 -2.09 -3.12 -2.19 -2.72 -4.71

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24


16.63 18.00 19.62 21.56 21.56 21.56
-30.92 -43.00 -62.35 -96.65 -121.02 -140.78
53.38 66.22 111.14 143.10 183.37 193.68
103.27 92.58 90.81 121.79 91.07 103.72
142.36 133.80 159.22 189.80 174.98 178.18
101.27 105.29 117.93 138.71 147.31 149.96
3.48 4.19 11.94 8.38 4.09 2.00

37.61 24.32 29.35 42.71 23.58 26.22


142.36 133.80 159.22 189.80 174.98 178.18
2.91 0.20 0.30 0.88 0.53 1.90
8.96 15.00 16.60 25.56 11.95 9.80
17.32 0.17 0.71 0.10 0.09 0.14
16,630,000.00 18,000,000.00 19,620,000.00 21,560,000.00 21,560,000.00 21,560,586.00

10.00 10.00 10.00 10.00 10.00 10.00

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24


3.90 -35.50 -14.57 -17.22 -24.71 2.30
-4.32 -10.22 -22.55 -22.90 -12.65 -7.82
17.32 28.58 37.66 39.51 37.34 5.56
16.90 -17.14 0.54 -0.61 -0.01 0.05

114.45 77.75 85.95 143.05 56.50 61.45

1.66 1.80 1.96 2.16 2.16 2.16

You might also like